Directorate Change

IQE PLC 10 December 2004 Press Release 10 December 2004 IQE plc ('the Group' or 'the Company') New Board Appointments and Directors shareholding IQE plc, a leading supplier of advanced semiconductor wafers to the world market, is pleased to announce the appointment of two executive directors to the main board of the Group with immediate effect. Stuart Andrew Hall, 37, has been appointed to the position of Chief Financial Officer and Dr Howard Robert Williams, 50, to the position of Chief Operating Officer. Stuart Hall joined IQE plc in July 2003 from Energis plc, having previously been in senior finance roles within the manufacturing sector. Over the last 17 months, Stuart has been acting CFO to the Group and has been instrumental in the Group's recent re-organisations, including the equity fundraising at the end of last year. Dr Williams has been with the Group for over 15 years, serving in a variety of posts including General Manager of IQE Inc in Bethlehem, Pennsylvania, and General Manager of IQE Europe. He has also been a Director of IQE Europe for over 8 years Dr Godfrey Ainsworth, Chairman of IQE plc, said ' I am extremely pleased to welcome both Howard and Stuart to the Board of IQE plc. Their combined talents, experience and commitment will contribute strongly to the future growth and success of the Group' Furthermore, the Company today announces the granting of share options over ordinary shares of 1p each in IQE plc ('Ordinary Shares') under the IQE plc executive share option plan ('Share Options') to both Mr Hall and Dr Williams, together with Dr Drew Nelson, President and CEO of IQE plc, as follows: Director No of Share Exercise Exercise period Resultant Total number Options Price (p) of Share Options held awarded Stuart 1,800,000* 10.167p 07 December 2007 - 2,000,000 Hall 07 December 2014 Howard 1,850,000* 10.167p 07 December 2007 - 2,229,050 Williams 07 December 2014 Drew 3,750,000* 10.167p 07 December 2007 - 3,750,000 Nelson 07 December 2014 *of these share options, 2,000,000 are granted subject to additional share purchases by the Directors concerned. The exercise of these Share Options is based upon the achievement of profitability performance criteria, including individual subsidiary Company profitability, Group profitability and Earnings per Share (EPS) growth in the top 50% of TechMark listed Companies As at today's date, Mr Hall is interested in 333,333 Ordinary Shares, representing approximately 0.11 per cent. of the Company's current issued share capital. These shares were purchased as part of the Company's placing in November 2003. Dr Williams has an interest in 15,000 Ordinary Shares and Dr Nelson has an interest in 26,724,637 Ordinary Shares, representing 8.51% of the Company's issued share capital. In the event that all issued options in IQE plc are exercised, the total shares issued would represent 6.0% of the total shares in issue. The Company confirms that there are no other disclosures required pursuant to Schedule Two of the AIM Rules. For further information, please contact IQE plc: Drew Nelson, President & CEO +44 29 2083 9400 Stuart Hall, CFO +44 29 2083 9400 Chris Meadows, Investor Relations Manager +44 29 2083 9400 Buchanan Communications : +44 20 7466 5000 Tim Thompson / Nicola Cronk Notes to Editors: About IQE: IQE is a leading outsource supplier of customised epitaxial wafers and compound semiconductor substrates to the global semiconductor industry. Materials produced by the Group operate at the forefront of technology, typically in high speed electronics and optical systems for a diverse range of devices including those used for data/audio/visual storage, optical communications, wireless and RF devices and systems as well as an increasing range of automotive, medical and industrial applications. This information is provided by RNS The company news service from the London Stock Exchange

Companies

IQE (IQE)
UK 100

Latest directors dealings